Peyronie's disease: an update of the medical management.
Peyronie's disease (PD) is characterised by penile plaque formation, pain, penile deformity and erectile dysfunction. It is a fibrotic disorder of the tunica albuginea with a poorly understood aetiology and epidemiology. PD may be classified into inflammatory (acute) and chronic stages. Medical treatment is usually instigated during the inflammatory phase of the disease. A review of the literature reveals a wide range of oral, intralesional and alternative therapies that are discussed in relation to established pathophysiological mechanisms of the disease. The advantages and disadvantages of each treatment are summarised. This review also discusses the ongoing therapeutic dilemmas of PD and suggests a treatment strategy based on an analysis of the urological literature.
Maan
Zafar
Z
Department of Urology, University of Rochester Medical Center, Rochester, New York 14642-8656, USA.
Arya
Manit
M
Shergill
Iqbal
I
Joseph
Jean V
JV
Patel
Hitendra R H
HR
D006801:Humans; D008297:Male; D010411:Penile Induration / Q000628:therapy*